(S (NP-SBJ-28 (NP Age-related/JJ decreases/NNS) (PP in/IN (NP (NP IL-2/NN production/NN) (PP by/IN (NP human/JJ T/NN cells/NNS))))) (VP are/VBP (VP associated/VBN (NP *-28/-NONE-) (PP with/IN (NP (NP impaired/JJ activation/NN) (PP of/IN (NP nuclear/JJ transcriptional/JJ factors/NNS (NP-COOD (NP AP-1/NN) and/CC (NP NF-AT/NN)))))))) ./.)
(S (SBAR Although/IN (S (NP-SBJ-COOD (NP transcriptional/JJ factors/NNS AP-1/NN) and/CC (NP (NP (NP nuclear/JJ factor/NN) (PP of/IN (NP activated/VBN T/NN cells/NNS))) (PRN -LRB-/-LRB- (NP NF-AT/NN) -RRB-/-RRB-))) (VP are/VBP (ADJP-PRD important/JJ) (PP for/IN (NP (NP the/DT normal/JJ induction/NN) (PP of/IN (NP IL-2/NN))))))) ,/, (NP-SBJ (NP it/PRP) (SBAR *EXP*-30/-NONE-)) (VP is/VBZ (ADJP-PRD unknown/JJ) (SBAR-30 if/IN (S (NP-SBJ-29 (NP the/DT age-related/JJ decline/NN) (PP in/IN (NP (NP IL-2/NN production/NN) (PP by/IN (NP activated/VBN human/JJ T/NN cells/NNS))))) (VP may/MD (VP be/VB (VP associated/VBN (NP *-29/-NONE-) (PP with/IN (NP (NP aberrancies/NNS) (PP in/IN (NP transcriptional/JJ regulatory/JJ proteins/NNS)))))))))) ./.)
(S (PP In/IN (NP the/DT current/JJ studies/NNS)) ,/, (NP-SBJ-31 (NP IL-2/NN production/NN) (PP by/IN (NP (NP T/NN cells/NNS) (PP from/IN (NP (ADJP-COOD (ADJP elderly/JJ (PRN -LRB-/-LRB- (S (NP-SBJ mean/NN) (NP-PRD 78/CD years/NNS)) -RRB-/-RRB-)) and/CC (ADJP young/JJ (PRN -LRB-/-LRB- (S (NP-SBJ mean/NN) (NP-PRD 37/CD years/NNS)) -RRB-/-RRB-))) humans/NNS))))) (VP was/VBD (VP measured/VBN (NP *-31/-NONE-) (PP in/IN (NP (NP cultures/NNS) (VP stimulated/VBN (NP */-NONE-) (PP with/IN (NP-COOD (NP PHA/NN) ,/, (NP-COOD (NP PHA/NN) plus/CC (NP PMA/NN)) ,/, (NP-COOD (NP crosslinked/VBN anti-CD3/JJ mAB/NN OKT3/NN) plus/CC (NP PMA/NN)) ,/, or/CC (NP-COOD (NP PMA/NN) plus/CC (NP ionomycin/NN))))))))) ./.)
(S-COOD (S (NP-SBJ-33 (NP Substantial/JJ decreases/NNS) (PP of/IN (NP IL-2/NN production/NN))) (VP were/VBD (VP observed/VBN (NP *-33/-NONE-) (PP for/IN (NP (NP cell/NN cultures/NNS) (PP from/IN (NP (QP 7/CD of/IN 12/CD) elderly/JJ individuals/NNS)))) (PP in/IN response/NN to/TO (NP the/DT different/JJ stimuli/NNS))))) ,/, whereas/IN (S (NP-SBJ (NP the/DT levels/NNS) (PP of/IN (NP (NP IL-2/NN) (VP produced/VBN (NP */-NONE-) (PP by/IN (NP-LGS (NP stimulated/VBN T/NN cells/NNS) (PP from/IN (NP other/JJ elderly/JJ individuals/NNS)))))))) (VP were/VBD (ADJP-PRD equivalent/JJ (PP to/TO (NP (NP those/DT) (VP observed/VBN (NP */-NONE-) (PP for/IN (NP (NP stimulated/VBN T/NN cells/NNS) (PP of/IN (NP young/JJ subjects/NNS)))))))))) ./.)
(S (NP-SBJ (NP Analyses/NNS) (PP of/IN (NP nuclear/JJ extracts/NNS)) (PP by/IN (NP electrophoretic/JJ DNA/NN mobility/NN shift/NN assays/NNS))) (VP showed/VBD (SBAR that/IN (S (NP-SBJ-35 (NP decreased/VBN IL-2/NN production/NN) (PP by/IN (NP (NP stimulated/VBN T/NN cells/NNS) (PP of/IN (NP elderly/JJ individuals/NNS))))) (VP was/VBD (ADVP closely/RB) (VP associated/VBN (NP *-35/-NONE-) (PP with/IN (NP (NP impairments/NNS) (PP in/IN (NP (NP the/DT activation/NN) (PP of/IN (NP-COOD both/CC (NP AP-1/NN) and/CC (NP NF-AT/NN)))))))))))) ./.)
(S (PP By/IN (NP contrast/NN)) ,/, (NP-SBJ (NP T/NN cells/NNS) (PP from/IN (NP (NP elderly/JJ subjects/NNS) (PP with/IN (NP (NP normal/JJ levels/NNS) (PP of/IN (NP IL-2/NN production/NN))))))) (VP exhibited/VBD (NP (NP normal/JJ activation/NN) (PP of/IN (NP-COOD (NP AP-1/NN) and/CC (NP NF-AT/NN))))) ./.)
(S (PP In/IN (NP addition/NN)) ,/, (NP-SBJ (NP the/DT results/NNS) (PP of/IN (NP (NP competition/NN experiments/NNS) (VP analyzing/VBG (NP (NP the/DT normal/JJ components/NNS) (PP of/IN (NP NF-AT/NN))))))) (VP showed/VBD (SBAR that/IN (S (NP-SBJ (NP the/DT age-related/JJ reductions/NNS) (PP in/IN (NP stimulus-dependent/JJ NF-AT/NN complexes/NNS))) (VP corresponded/VBD (PP to/TO (NP (NP the/DT (ADJP slow/JJ migrating/VBG) complexes/NNS) (SBAR (WHNP-36 that/WDT) (S (NP-SBJ-37 *T*-36/-NONE-) (VP were/VBD (VP composed/VBN (NP *-37/-NONE-) (PP of/IN (NP c-Fos\/c-Jun/NN AP-1/NN)))))))))))) ./.)
(S (S (NP-SBJ-38 (NP The/DT (ADJP-COOD (ADJP resting/JJ) and/CC (ADJP stimulated/JJ)) levels/NNS) (PP of/IN (NP NF/NN kappa/NN B/NN))) (VP were/VBD (VP reduced/VBN (NP *-38/-NONE-) (PP in/IN (NP (NP T/NN cells/NNS) (PP from/IN (NP certain/JJ elderly/JJ individuals/NNS)))))) ;/:) (S (ADVP however/RB) ,/, (NP-SBJ (NP alterations/NNS) (PP of/IN (NP NF/NN kappa/NN B/NN))) (VP did/VBD not/RB (VP correlate/VB (PP with/IN (NP (NP changes/NNS) (PP in/IN (NP IL-2/NN expression/NN)))))) ./.))
(S (ADVP Thus/RB) ,/, (NP-SBJ these/DT results/NNS) (VP-COOD (VP show/VBP (SBAR that/IN (S (NP-SBJ-39 (NP age-related/JJ impairments/NNS) (PP in/IN (NP (NP the/DT activation/NN) (PP of/IN (NP-COOD (NP AP-1/NN) and/CC (NP NF-AT/NN)))))) (VP are/VBP (ADVP closely/RB) (VP associated/VBN (NP *-39/-NONE-) (PP with/IN (NP (NP decreased/VBN expression/NN) (PP of/IN (NP IL-2/NN))))))))) and/CC (VP (ADVP further/RB) suggest/VBP (SBAR that/IN (S (NP-SBJ (NP aberrancies/NNS) (PP in/IN (NP the/DT signaling/NN pathways/NNS)) (ADJP important/JJ (PP for/IN (NP (NP the/DT induction/NN) (PP of/IN (NP (ADJP transcriptionally/RB active/JJ) c-Fos\/c-Jun/NN AP-1/NN)))))) (VP may/MD (VP contribute/VB (PP to/TO (NP (NP the/DT impaired/JJ activation/NN) (PP of/IN (NP NF-AT/NN)))))))))) ./.)
